2nd Quarter - Report

COHERUS BIOSCIENCES for COHERUS BIOSCIENCES, INC.

Firm
Client
Income
—
Expenses
$250,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Build Back Better Act Drug Pricing Reform ASP+8 for biosimilars Domestic Manufacturing Medicare implications on biosimilars Appropriations pertaining to FDA inspections HHS Supply Chain Readiness HHS Biosimilar Uptake American-Made, Security of the American Pharmaceutical and Medical Supply Chain H.R. 2815 - The BIOSIM Act H.R. 2869 / S. 1427 - Increasing Access to Biosimilars Act of 2021 H.R. 2855 - Star Rating for Biosimilars S. 2082 - Manufacturing API, Drugs, and Excipients (MADE) in America Act S. 1176 - Onshoring Essential Antibiotics Act S. 1693 - Medical Supplies for Pandemics Act 340B Drug Pricing Program HR 3683 Securing America's Pharmaceutical Supply Chain S 2640 Disease X Act S. 2662 Industrial Finance Corporation Act American Made Pharmaceutical Act

LobbyistCovered position, as disclosed
BEN KENNEY Director of Strategic Communications and Stakeholder Engagement, Centers for Medicare and Medicaid Services (2018-2021), Associate Administrator, General Services Administration (2017-2018), Legislative Aide, U.S. Sen. Daniel R. Coats (2011-2012)
AMANDA MAJOR —
DAVID SANDERS Legislative Affairs, Dept of Commerce, US Patent and Trademark Office (2005-2007) Legislative Assistant, Representative Marsha Blackburn (2002-2004) Legislative and Press Intern, Senator Fred Thompson (2000)

Contacted: Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Office of Science & Technology Policy (OSTP); Defense, Dept of (DOD); SENATE; Centers For Medicare and Medicaid Services (CMS); Natl Security Council (NSC); Office of Management & Budget (OMB); White House Office

Bills named: H.R. 2869 (117th), H.R. 3683 (117th), H.R. 2815 (117th), S. 2662 (117th), S. 1693 (117th), S. 1427 (117th), S. 1176 (117th), S. 2082 (117th), H.R. 2855 (117th)

Government Issues GOV

Implementation of Buy American and Supply Chain Executive Orders American-Made Policies American-Made Supply Chain Security of the American Pharmaceutical and Medical Supply Chain Drug Pricing Reform Biosimilars Policy BARDA ASPR ARPA-H Industrial Supply and Financing

LobbyistCovered position, as disclosed
BEN KENNEY CMS, HHS
AMANDA MAJOR —
DAVID SANDERS —

Contacted: Health & Human Services, Dept of (HHS); SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES; White House Office; Office of Management & Budget (OMB); Executive Office of the President (EOP)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.